During his keynote presentation to be made at NEXUS '17, Jean-Marc Bobée, former director, industrial anti-counterfeiting strategy at Sanofi, will outline global and local traceability concepts and their individual ‘security to cost’ ratios, highlighting the need for a standardised global serialisation.
Unsecured global supply chains and rising internet sales have led to a proliferation of counterfeit drugs. In an era of growing supply chain complexity and globalisation, pharmaceutical companies and governments are increasingly recognising that serialisation can help reduce fraudulent medicines from entering the market.